RegMed XB: het is in 2016 dat Clemens van Blitterswijk samen met Marianne van der Steen, Tom Oostrom en anderen begon aan een ambitieuze reis om een translationeel instituut te creëren dat zich richt op baanbrekende projecten in regeneratieve geneeskunde. 

Representatives of RegMed XB and the RegMed XB Pilot Factory recently traveled to Japan to visit several prime regenerative medicine centers such as CIRA in Kyoto and Osaka University and participate in the EU-Japan Biotech & Pharma Partnering Conference 2023 in Osaka and Bio Japan in Yokohama. 

The first edition of the Advanced Therapies Summit, held on October 19th, was a success. Dr. Bart Geers, Chair of the Board at RegMed XB Flanders, welcomed over 170 participants from both Belgium and across the European Union.